Literature DB >> 16076731

Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat.

E M Lenz1, J Bright, R Knight, F R Westwood, D Davies, H Major, I D Wilson.   

Abstract

The model nephrotoxin gentamicin was administered to male Wistar-derived rats daily, for 7 days, at 60 mg kg-1 day-1, subcutaneously, twice daily. Conventional clinical chemistry urinalysis showed a significant increase in N-acetyl-beta-D-glucosaminidase (NAG) activity from day 3. At necropsy on day 9, clear histological damage to the kidney was noted with all animals showing a generally severe nephropathy primarily focused on the proximal convoluted tubules. The urinary excretion pattern of endogenous metabolites over the time course of the study was studied using a combination of 1H-NMR spectroscopy and HPLC-TOF-MS/MS using electrospray ionization (ESI). Changes in the pattern of endogenous metabolites as a result of daily administration of gentamicin were readily detected by both techniques with significant perturbations of the urinary profile observed from day 7 onwards. The findings by 1H-NMR included raised glucose and reduced trimethylamine N-oxide (TMAO). Changes in metabonomic profiles were observed by HPLC-MS in both positive and negative ESI. The MS data showed reduced xanthurenic acid and kynurenic acid, whilst neutral loss experiments also revealed a changed pattern of sulphate conjugation on gentamicin administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16076731     DOI: 10.1080/13547500500094034

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  22 in total

Review 1.  Metabonomics techniques and applications to pharmaceutical research & development.

Authors:  John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

Review 2.  Biomarkers for neuroAIDS: the widening scope of metabolomics.

Authors:  Gurudutt Pendyala; Elizabeth J Want; William Webb; Gary Siuzdak; Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2006-10-10       Impact factor: 4.147

Review 3.  Metabolomics as an extension of proteomic analysis: study of acute kidney injury.

Authors:  Didier Portilla; Laura Schnackenberg; Richard D Beger
Journal:  Semin Nephrol       Date:  2007-11       Impact factor: 5.299

4.  Highly-parallel metabolomics approaches using LC-MS for pharmaceutical and environmental analysis.

Authors:  Sunil Bajad; Vladimir Shulaev
Journal:  Trends Analyt Chem       Date:  2007-06-01       Impact factor: 12.296

5.  The Opportunities of Metabolomics in Drug Safety Evaluation.

Authors:  Pengcheng Wang; Amina I Shehu; Xiaochao Ma
Journal:  Curr Pharmacol Rep       Date:  2017-01-03

6.  Does the mass spectrometer define the marker? A comparison of global metabolite profiling data generated simultaneously via UPLC-MS on two different mass spectrometers.

Authors:  Helen G Gika; Georgios A Theodoridis; Mark Earll; Rodney W Snyder; Susan J Sumner; Ian D Wilson
Journal:  Anal Chem       Date:  2010-10-01       Impact factor: 6.986

7.  Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).

Authors:  William R Wikoff; Megha A Nagle; Valentina L Kouznetsova; Igor F Tsigelny; Sanjay K Nigam
Journal:  J Proteome Res       Date:  2011-04-22       Impact factor: 4.466

8.  Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity.

Authors:  Max Sieber; Dana Hoffmann; Melanie Adler; Vishal S Vaidya; Matthew Clement; Joseph V Bonventre; Nadine Zidek; Eva Rached; Alexander Amberg; John J Callanan; Wolfgang Dekant; Angela Mally
Journal:  Toxicol Sci       Date:  2009-04-06       Impact factor: 4.849

9.  The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity.

Authors:  Parvaneh Espandiari; Jun Zhang; Barry A Rosenzweig; Vishal S Vaidya; Jinchun Sun; Laura Schnackenberg; Eugene H Herman; Alan Knapton; Joseph V Bonventre; Richard D Beger; Karol L Thompson; Joseph Hanig
Journal:  Toxicol Sci       Date:  2007-07-17       Impact factor: 4.849

10.  Metabonomics of acute kidney injury in children after cardiac surgery.

Authors:  Richard D Beger; Ricky D Holland; Jinchun Sun; Laura K Schnackenberg; Page C Moore; Catherine L Dent; Prasad Devarajan; Didier Portilla
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.